jama semaglutide Study links Wegovy to increased NAION incidence in diabetes patients Study comparing Mounjaro and Ozempic

Approval: 2017 Injection: 2 mg/1.5 mL (1.34 mg/mL) available in: Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection

Disclaimer: Products sold are intended strictly for laboratory research use only and in vitro experimentation

90% of GLP-1 patients reported frequent food-related thoughts before treatment (Signal in the Food Noise, 2026) 61% of women described food noise as constant, vs 20% of men, before starting treatment (Signal in the Food Noise, 2026) 4x greater reduction in food noise with GLP-1 combined with behavioural therapy vs therapy alone (ECO2026 / Pennington Biomedical) 3.3M UK adults expected to use weight loss injections in 2026 (NPA / YouGov poll) What Exactly Is Food Noise

Approximately half of those (N=7,256) had ASCVD and obesity without diabetes mellitus (3.16% of ASCVD patients)

Adalvo announces that it will submit its DCP application for Semaglutide (generic for Ozempic) in February 2026, aligned with the expiry of data exclusivity

GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M